|
1
|
Menbari MN, Nasseri S, Menbari N,
Mehdiabadi R, Alipur Y and Roshani D: The-160 (C>A) CDH1 gene
promoter polymorphism and its relationship with survival of
patients with gastric cancer in Kurdistan. Asian Pac J Cancer Prev.
18:1561–1565. 2017.PubMed/NCBI
|
|
2
|
Jmour O, Belaïd A, Mghirbi F, Béhi K,
Doghri R and Benna F: Gastric metastasis of bilateral breast
cancer. J Gastrointest Oncol. 8:E16–E20. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen Q, Li K, Tian S, Yu TH, Yu LH, Lin HD
and Bai DQ: Photodynamic therapy mediated by aloe-emodin inhibited
angiogenesis and cell metastasis through activating MAPK signaling
pathway on HUVECs. Technol Cancer Res Treat.
17:15330338187855122018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhao C, Su Y, Zhang J, Feng Q, Qu L, Wang
L, Liu C, Jiang B, Meng L and Shou C: Fibrinogen-derived
fibrinostatin inhibits tumor growth through anti-angiogenesis.
Cancer Sci. 106:1596–1606. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chamorro-Jorganes A, Lee M, Araldi E,
Landskroner-Eiger S, Fernández-Fuertes M, Sahraei M, Quiles Del Rey
M, van Solingen C, Yu J, Fernández-Hernando C, et al: VEGF-induced
expression of miR-17-92 cluster in endothelial cells is mediated by
ERK/ELK1 activation and regulates angiogenesis. Circ Res.
118:38–47. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Garikipati V, Singh S, Mohanram Y, Gupta
A, Kapoor D and Nityanand S: Isolation and characterization of
mesenchymal stem cells from human fetus heart. PLoS One.
13:e01922442018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Plummer P, Freeman R, Taft RJ, Vider J,
Sax M, Umer BA, Gao D, Johns C, Mattick JS, Wilton SD, et al:
MicroRNAs regulate tumor angiogenesis modulated by endothelial
progenitor cells. Cancer Res. 73:341–352. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Grigoras D, Pirtea L and Ceausu RA:
Endothelial progenitor cells contribute to the development of
ovarian carcinoma tumor blood vessels. Oncol Lett. 7:1511–1514.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen H, Campbell RA, Chang Y, Li M, Wang
CS, Li J, Sanchez E, Share M, Steinberg J, Berenson A, et al:
Pleiotrophin produced by multiple myeloma induces
transdifferentiation of monocytes into vascular endothelial cells:
A novel mechanism of tumor-induced vasculogenesis. Blood.
113:1992–2002. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang X, Xu W, Wang S, Yu F, Feng J, Wang
X, Zhang L and Lin J: Transdifferentiation of human MNNG/HOS
osteosarcoma cells into vascular endothelial cells in vitro
and in vivo. Oncol Rep. 38:3153–3159. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Soda Y, Marumoto T, Friedmann-Morvinski D,
Soda M, Liu F, Michiue H, Pastorino S, Yang M, Hoffman RM, Kesari S
and Verma IM: Transdifferentiation of glioblastoma cells into
vascular endothelial cells. Proc Natl Acad Sci USA. 108:4274–4280.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tang S, Xiang T, Huang S, Zhou J, Wang Z,
Xie R, Long H and Zhu B: Ovarian cancer stem-like cells
differentiate into endothelial cells and participate in tumor
angiogenesis through autocrine CCL5 signaling. Cancer Lett.
376:137–147. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pezzolo A, Marimpietri D, Raffaghello L,
Cocco C, Pistorio A, Gambini C, Cilli M, Horenstein A, Malavasi F
and Pistoia V: Failure of anti tumor-derived endothelial cell
immunotherapy depends on augmentation of tumor hypoxia. Oncotarget.
5:10368–10381. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang H, Wu H, Zheng J, Yu P, Xu L, Jiang
P, Gao J, Wang H, Zhang Y, et al: Transforming growth factor β1
signal is crucial for dedifferentiation of cancer cells to cancer
stem cells in osteosarcoma. Stem Cells. 31:433–446. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin SC, Liao WL, Lee JC and Tsai SJ:
Hypoxia-regulated gene network in drug resistance and cancer
progression. Exp Biol Med (Maywood). 239:779–792. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang X, Yin H, Zhang Y, Li X, Tong H, Zeng
Y, Wang Q and He W: Hypoxia-induced autophagy promotes gemcitabine
resistance in human bladder cancer cells through hypoxia-inducible
factor 1α activation. Int J Oncol. 53:215–224. 2018.PubMed/NCBI
|
|
17
|
Joshi S, Singh A and Durden D: MDM2
regulates hypoxic hypoxia-inducible factor 1α stability in an E3
ligase, proteasome, and PTEN-phosphatidylinositol
3-kinase-AKT-dependent manner. J Biol Chem. 289:22785–22797. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park C, Ivanova I and Kenneth N: XIAP
upregulates expression of HIF target genes by targeting HIF1α for
Lys63-linked polyubiquitination. Nucleic Acids Res. 45:9336–9347.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim TH, Hur E, Kang SJ, Kim JA, Thapa D,
Lee YM, Ku SK, Jung Y and Kwak MK: NRF2 blockade suppresses colon
tumor angiogenesis by inhibiting hypoxia-induced activation of
HIF-1α. Cancer Res. 71:2260–2275. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Greenberger LM, Horak ID, Filpula D, Sapra
P, Westergaard M, Frydenlund HF, Albaek C, Schrøder H and Ørum H: A
RNA antagonist of hypoxia-inducible factor-1alpha, EZN-2968,
inhibits tumor cell growth. Mol Cancer Ther. 7:3598–3608. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Toffoli S, Roegiers A, Feron O, Van
Steenbrugge M, Ninane N, Raes M and Michiels C: Intermittent
hypoxia is an angiogenic inducer for endothelial cells: Role of
HIF-1. Angiogenesis. 12:47–67. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shen C, Burke Z and Tosh D:
Transdifferentiation, metaplasia and tissue regeneration.
Organogenesis. 1:36–44. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chera S, Ghila L, Dobretz K, Wenger Y,
Bauer C, Buzgariu W, Martinou JC and Galliot B: Apoptotic cells
provide an unexpected source of Wnt3 signaling to drive hydra head
regeneration. Dev Cell. 17:279–289. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lugus J, Park C, Ma Y and Choi K: Both
primitive and definitive blood cells are derived from Flk-1+
mesoderm. Blood. 113:563–566. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Crippa L, Gasparri A, Sacchi A, Ferrero E,
Curnis F and Corti A: Synergistic damage of tumor vessels with
ultra low-dose endothelial-monocyte activating polypeptide-II and
neovasculature-targeted tumor necrosis factor-alpha. Cancer Res.
68:1154–1161. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tahmasebi Birgani Z, Fennema E, Gijbels M,
de Boer J, van Blitterswijk C and Habibovic P: Stimulatory effect
of cobalt ions incorporated into calcium phosphate coatings on
neovascularization in an in vivo intramuscular model in goats. Acta
Biomater. 36:267–276. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li B, Nie Z, Zhang D, Wu J, Peng B, Guo X,
Shi Y, Cai X, Xu L and Cao F: Roles of circulating endothelial
progenitor cells and endothelial cells in gastric carcinoma. Oncol
Lett. 15:324–330. 2018.PubMed/NCBI
|
|
29
|
Acurio J, Troncoso F, Bertoglia P, Salomon
C, Aguayo C, Sobrevia L and Escudero C: Potential role of A2B
adenosine receptors on proliferation/migration of fetal endothelium
derived from preeclamptic pregnancies. Biomed Res Int.
2014:2745072014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Longchamp A, Mirabella T, Arduini A,
MacArthur MR, Das A, Treviño-Villarreal JH, Hine C, Ben-Sahra I,
Knudsen NH, Brace LE, et al: Amino acid restriction triggers
angiogenesis via GCN2/ATF4 regulation of VEGF and H2S
production. Cell. 173:117–129.e114. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lam E, Francis R and Petkovic M: FOXO
transcription factors: Key regulators of cell fate. Biochem Soc
Trans. 34:722–726. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sisci D, Maris P, Cesario MG, Anselmo W,
Coroniti R, Trombino GE, Romeo F, Ferraro A, Lanzino M, Aquila S,
et al: The estrogen receptor α is the key regulator of the
bifunctional role of FoxO3a transcription factor in breast cancer
motility and invasiveness. Cell Cycle. 12:3405–3420. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sun X, Wang X, Tang Z, Grivainis M, Kahler
D, Yun C, Mita P, Fenyö D and Boeke JD: Transcription factor
profiling reveals molecular choreography and key regulators of
human retrotransposon expression. Proc Natl Acad Sci USA.
115:E5526–E5535. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kohu K, Sato T, Ohno SI, Hayashi K, Uchino
R, Abe N, Nakazato M, Yoshida N, Kikuchi T, Iwakura Y, et al:
Overexpression of the Runx3 transcription factor increases the
proportion of mature thymocytes of the CD8 single-positive lineage.
J Immunol. 174:2627–2636. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu T, Sims D and Baum B: Parallel RNAi
screens across different cell lines identify generic and cell
type-specific regulators of actin organization and cell morphology.
Genome Biol. 10:R262009. View Article : Google Scholar : PubMed/NCBI
|
